AI assistant
Sending…
Merck & Co., Inc. — Director's Dealing 2019
Nov 1, 2019
284_dirs_2019-11-01_140df597-e266-4c64-bedf-a7ab4199eeff.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2019-10-30
Reporting Person: Nally Michael (EVP, Chief Marketing Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-10-30 | Common Stock | M | 2287.0000 | $0.0000 | Acquired | 6195.7100 | Direct |
| 2019-10-30 | Common Stock | F | 652.0000 | $85.1000 | Disposed | 5543.7100 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-10-30 | Restricted Stock Unit | $ | M | 2287.0000 | Disposed | 2021-10-30 | Common Stock (2287.0000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock - 401(k) Plan | 1541.1159 | Indirect |
Footnotes
F1: Holdings include shares acquired in dividend reinvestment transactions.
F2: Includes shares acquired and dividends earned through October 7, 2019, in the Merck U.S. Savings Plan, a 401(k) plan.
F3: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
F4: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 10/30/2019, 10/30/2020 and 10/30/2021.
More from Merck & Co., Inc.
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 13
Interim / Quarterly Report
2026
May 4
Major Shareholding Notification
2026
Apr 30
Regulatory Filings
2026
Apr 30
Annual Report
2026
Apr 8
Proxy Solicitation & Information Statement
2026
Apr 8